SCAT1 and esophageal squamous cell carcinoma: It’s reported that SCAT1 as a component of the three-lncRNA signature predicting pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy shows a compellent prognostic value in patients [40].